Articles tagged with Antibiotic Resistance
New research reveals that healthy newborn babies' gut bacteria do not contain multi-drug resistant strains of common hospital pathogens. The study found multiple synergistic relationships between different bacteria, which could potentially be harnessed to outcompete resistant or harmful bacterial strains.
A new study maps the global landscape of antimicrobial resistance, revealing surprising transmissions in Sub-Saharan Africa and highlighting the need for tailored strategies to combat resistance. The research, which analyzed sewage samples from 243 cities in 101 countries, found that resistance genes are more frequently transmitted acr...
Researchers have uncovered a new mechanism of antibiotic resistance in Group A Streptococcus bacteria, making antibiotics ineffective and potentially leading to poor outcomes. The discovery highlights the complexity of understanding AMR and emphasizes the need for rapid diagnostic tools and therapeutics.
A post-pandemic outbreak of a drug-resistant fungus in Brazil was linked to the misuse of medications and full ICUs. The study found that 90% of infected patients had strains resistant to fluconazole and echinocandins, leading to high mortality rates.
A collaborative research team led by Dr Philip Li from HKUMed has pioneered a new nurse-led penicillin allergy triage and testing strategy, which demonstrated its effectiveness and safety compared to traditional allergy testing. The study found that 90% of penicillin allergy labels in Hong Kong are incorrect, leading to potential letha...
Researchers discovered antibiotic-resistant bacteria can travel from the gut to the lungs in a patient, highlighting the importance of preventing pathogenic bacteria from translocating to vital organs. The study's findings suggest eliminating resistant bacteria from the gut microbiome could help prevent serious infections.
A recent study found that superbugs in the environment rarely transmit to humans, contrary to previous fears. The researchers discovered high levels of antimicrobial-resistant bacteria in livestock, pets, and environmental samples, but surprisingly little overlap between hospital and environmental strains.
Climate change is expanding the geographic range of endemic fungal diseases, such as Valley fever, blastomycosis, and histoplasmosis, which can mimic pneumonia. Physicians are often misdiagnosing these conditions due to a lack of training and limited testing options.
The number of Candida auris cases in the EU/EEA nearly doubled between 2020 and 2021, with 11% of cases having no available information on carriage or infection. Early detection is crucial to prevent the spread of this healthcare-associated pathogen.
Researchers developed a technique to measure long-term effects of antibiotic combinations, finding some combinations may reduce treatment effectiveness. Specific combinations were found to prevent resistance development and protect patients from aggressive bacteria.
A new label indicating responsible antibiotic use (RAU) in dairy milk could entice conventional farmers to minimize antibiotics, with half of US adults willing to buy RAU-labeled milk. The price point would need to be competitive with conventional milk, but consumers are more willing to pay for the label.
A new treatment option for multi-resistant bacteria has been identified by a UNIGE team, which uses the drug edoxudine to weaken the defence mechanisms of Klebsiella pneumoniae, making it easier to eliminate. This approach could be a game-changer in the fight against antibiotic resistance.
A new study by Ochsner pharmacist Kevin Lin suggests that oral cephalosporins are as safe and effective as fluoroquinolones for treating acute kidney infections. The study's findings support the use of narrower-spectrum antibiotics to reduce antimicrobial resistance, a growing concern in healthcare.
Researchers at Osaka University have discovered the spatial characteristics of an efflux pump that helps bacteria resist antibiotics. By analyzing a specific inhibitor's binding site, they found bulky mutations can prevent the inhibitor from working, offering hope for developing new countermeasures to combat antibiotic resistance.
A study by University of Portsmouth researchers reveals how hydroquinine kills Pseudomonas aeruginosa, a type of bacteria resistant to many antibiotics. The compound alters the expression levels of virulence factors and interferes with bacterial movement, making it an effective weapon against drug-resistant infections.
A randomized clinical trial found that applying topical antibiotics to the upper digestive tract can improve survival rates in mechanically ventilated intensive care patients. The study, published in JAMA, also showed a significant reduction in new hospital-acquired infections.
A new drug combination of cefepime and enmetazobactam has been found to be more effective in treating complicated urinary tract infections and acute pyelonephritis than a standard treatment. The study showed that the new combination was successful in treating 79% of patients, compared to 58.9% for the conventional treatment.
A recent study by University of Gothenburg researchers found that nearly twice as many Swedes are willing to obtain antibiotics without prescriptions than previously thought. Trust in healthcare plays a significant role in this behavior, with low trust linked to increased prescription without a doctor's order.
Researchers have developed a novel method for antibiotic resistance testing that can analyze bacterial cells in real-time, allowing for faster identification of susceptible and resistant bacteria. This breakthrough technology has the potential to transform microbial screening in clinical and research labs.
Researchers have successfully blocked the adhesion mechanism of Bartonella henselae bacteria, preventing cell infection. The discovery offers a promising new approach to combat highly resistant infectious agents like Acinetobacter baumannii.
The WHO European Region sees high mortality rates due to antimicrobial resistance, with countries implementing national actions plans showing lower AMR burden. Developing new treatments and improving hygiene are crucial strategies to combat this growing health threat.
Research by the University of Exeter found high levels of antibiotic ciprofloxacin in UK wastewater, posing a significant risk to human health. The study suggests that antibiotic pollution from human waste can increase resistance to antibiotics, even in countries with well-established sanitation infrastructures.
A new platform has been created using 214,000 microbiome samples to track antibiotic-resistant bacteria globally. The data can be used to tailor guidelines on combating resistance in different regions.
Scientists at the University of Bath have discovered a novel polyamine that destroys MRSA superbug Staphylococcus aureus by disrupting its cell membrane, rendering it susceptible to antibiotics. The compound is also effective against biofilm and has shown promise as a potential new treatment option for antibiotic-resistant infections.
Researchers have identified a new antifungal antibiotic named solanimycin produced by a pathogenic potato bacterium. The compound shows efficacy against various fungi, including Candida albicans, and has potential for both agricultural and clinical applications.
A clinical trial is underway to evaluate the safety and efficacy of bacteriophage therapy in adults with cystic fibrosis who carry Pseudomonas aeruginosa. The trial aims to reduce bacterial load in the lungs using a phage cocktail that targets specific bacteria, providing a potential new treatment for difficult-to-treat infections.
Researchers found that Carbapenemase-producing Enterobacteriaceae (CPE) colonizes the gut without symptoms, depleting key bacteria and leaving tell-tale marks. Rebalancing gut bacteria may help promote CPE decolonization and prevent antibiotic resistance transmission.
A new single-cell functional tool has been developed to screen and sequence active antibiotic-resistant bacteria (ARB) in native soils. The study found that the percentage and activity of ARB in soils were elevated with human activity, highlighting the need for control technologies.
A new study by the University of Bern has discovered 21 highly-active metal compounds that demonstrate good activity against various resistant fungal strains. These compounds were up to 30,000 times more active against fungi than human cells.
A new project will explore the defence mechanisms of bacterial cells to stop the spread of drug-resistant genes. The team, led by Professor Edze Westra, will use a range of methods to understand how bacteria defend against mobile genetic elements (MGEs) that contribute to antimicrobial resistance.
Researchers used Raman spectroscopy to identify and analyze Escherichia coli persister cells, finding they have enhanced metabolic activities despite being in a dormant state. This new understanding could lead to the development of novel therapeutic strategies.
Researchers found that poor infrastructures, low awareness, and unstable funding hinder efforts to implement global guidelines for antimicrobial resistance. The study highlights the need for tailored interventions responsive to local needs.
The Society for Healthcare Epidemiology of America highlights the need to strengthen antibiotic stewardship programs to address overuse of antibiotics in early stages of viral epidemics. The guidance provides strategies for hospitals and healthcare personnel to improve antibiotic prescribing and diagnostic testing.
Researchers used E. coli as an indicator of antimicrobial resistance in Canadian turkey flocks. They found that antimicrobial use in feed and injection into eggs were main drivers of resistance. The study suggests that disease treatment also contributes to the development of resistance.
Researchers at Imperial College London discovered a 'silent' mutation in bacteria that helps them evade antibiotics. The mutation alters the structure of an mRNA intermediate, preventing ribosomes from producing protein, and has arisen independently several times globally.
Scientists found that weedy rice has developed herbicide resistance through gene flow from crop rice, with most fields showing resistant plants within 20 years of herbicide-resistant rice cultivation. This rapid evolution is due to the close proximity of weedy and crop rice in the same fields, allowing for pollen transfer and outcrossing.
Scientists at Aston University developed a new treatment combining manuka honey with the widely used antibiotic amikacin to treat drug-resistant lung infections. The study found that this combination improved bacterial clearance and reduced side effects, benefiting patients with cystic fibrosis.
A novel method developed by Brazilian researchers can analyze bacterial samples without isolating live bacteria, making it easier to detect antibiotic resistance in Streptococcus pneumoniae. The technique was tested on 873 samples and found that 51% were sensitive to antibiotics, while 17% were resistant.
A new study from MIT reveals that computer models predicting molecular interactions, like AlphaFold, need improvement to help identify drug mechanisms of action. Researchers improved the performance of these models using machine-learning techniques, but more work is needed.
Researchers have found hydroquinine, an organic compound found in tree bark, has potent antibacterial properties against several microorganisms. The study suggests it may be a potential candidate for future clinical investigation to combat antibiotic-resistant infections.
A study by Taiwanese researchers found that patients with atherosclerosis are at higher risk for life-threatening vascular infections from non-typhoidal Salmonella bacteremia. The study suggests the use of a scoring system to predict infection risk and identifies interleukin-1 beta as a potential biomarker.
Researchers developed a light-based therapy, photodynamic therapy (aPDT), to combat antibiotic-resistant bacteria. The treatment showed promise in weakening bacteria, allowing lower doses of current antibiotics to effectively eliminate them.
A new class of light-activated hemithioindigo molecules developed by Rice University scientists kill specific Gram-positive bacteria and their biofilms. The molecules induce reactive oxygen species that chemically attack and destroy drug-resistant cells, offering a safer alternative to conventional antibiotics.
Researchers identified four categories of antimicrobial stewardship programs: Collaborative Model, Centrally Coordinated Model, Centrally Led Model, and Collaborative, Consultative Network Model. The study aims to enhance patient care and reduce antibiotic resistance by understanding best practices in these models.
A new oral drug candidate, JSF-2659, has been developed to eradicate the bacteria causing gonorrhea. It works by simultaneously targeting two molecular targets, making it effective against resistant strains and reducing the risk of drug resistance.
Researchers have discovered a new molecule, fabimycin, that effectively treats over 300 drug-resistant bacteria in lab experiments and mice with pneumonia and urinary tract infections. The compound reduces the amount of drug-resistant bacteria to pre-infection levels or below, outperforming existing antibiotics at similar doses.
A massive analysis of over 10,000 Mycobacterium tuberculosis isolates revealed new genes associated with resistance to 13 antibiotics. The study provides a comprehensive framework for understanding the genetic mechanisms of resistance and identifying diagnostic gaps.
A new biosynthesis method has been developed to produce antibiotics from natural substances with added fluorine, which can strengthen bonding and improve accessibility. This technology has huge potential for optimizing polyketides, a gigantic substance class used in various medicines.
A new study published in Nature Microbiology reveals high prevalence of antibiotic resistance genes in mothers and neonates from 7 LMICs. The researchers found that ARGs were present in neonates within hours of birth, indicating initial colonization with antibiotic-resistant bacteria.
Researchers have discovered a new mechanism that some bacteria use to evade rifamycin antibiotics, showing antimicrobial resistance is more complex and evolved than previously recognized. The discovery has implications for finding new antibiotics and combating the growing global health threat of antimicrobial resistance.
Researchers at TUM have developed a cell-free production method for bacteriophages, which can be used to target and combat specific types of antibiotic-resistant bacteria. The new technology has the potential to produce personalized therapeutic phages for clinical trials, addressing multi-resistant germ infections.
Researchers at Texas A&M University's Center for Phage Technology have completed a study on phage therapy, identifying potential applications to fight multidrug-resistant bacterial infections. The study showed promise in treating Acinetobacter baumannii, a deadly pathogen found in hospital settings and the Middle East.
Researchers used a new tool to capture hundreds of undiscovered mechanisms of gene regulation in MRSA, revealing a previously unknown layer of gene regulation. The study identified a regulatory RNA that promotes an enzyme involved in cell wall thickening, potentially identifying new targets for antibiotic treatment.
Two studies found that dogs fed on a diet of raw meat were more likely to excrete antibiotic-resistant E. coli in their faeces. The research suggests that not feeding raw meat to dogs may help reduce the circulation of critically important antibiotic-resistant bacteria.
NC State researchers discovered a new way to make the difficult-to-characterize gut bacterium Bifidobacterium more responsive to antibiotics. They also found tiny changes in different strains that reflect large differences in their characteristics, highlighting the need for individualized CRISPR-based genome engineering approaches.
A new report highlights the importance of acknowledging antimicrobial resistance (AMR) in regulatory frameworks for accelerated drug approval. The analysis provides recommendations to improve access to new antibiotics in Brazil, India, and South Africa, where antibiotic development is hampered by regulatory hurdles.
Researchers at Ben-Gurion University have found a phytochemical derived from broccoli that breaks down biofilms protecting antibiotic-resistant pathogens, enabling eradication rates of up to 94% when combined with antibiotics. The compound also accelerates wound healing and is being further developed for commercialization.
Scientists have found that prior exposure to Staphylococcus aureus prevents effective vaccination due to immune response memory. To overcome this, the research suggests targeting only the protective component of the protein IsdB, generating a more effective vaccine against MRSA.
Researchers from Tianjin Medical University General Hospital review sarcopenic obesity's impact on liver disease, including nonalcoholic fatty liver disease and cirrhosis. The study aims to clarify the pathogenesis of sarcopenic obesity and identify potential therapeutic avenues.
A new study found that the O139 cholera variant lost antimicrobial resistance and changed toxin production, leading to its unexpected decline. The findings suggest continuous monitoring of genetic changes is key to preventing future outbreaks.